Important update to Anthem’s commercial drug lists

Effective with dates of service on and after October 1, 2019, and in accordance with Anthem’s Pharmacy and Therapeutic (P&T) process, Anthem will update its commercial drug lists. Updates may include changes to drug tiers or the removal of a drug.

To help ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a preferred drug to patients currently using a non-preferred drug, if appropriate.

Please note, this update does not apply to the Select Drug List or drugs lists utilized by the Federal Employee Program (FEP).

To view a summary of changes, open the PDF attached to this article titled “8.1.19 and 10.1.19 Summary_of_formulary_changes”.